Growth hormone-releasing hormone is a signal that stimulates growth hormone release; it is not growth hormone itself. Its research history also contains several peptide lengths, tissue sources and names. Reading that history carefully gives a stronger molecular reference than treating every GH-releasing preparation as the same substance.
Distinguish the releasing signal from the released hormone
NCBI’s GHRH gene record describes a hypothalamic precursor that is processed into the mature releasing factor. This factor stimulates growth hormone release from the pituitary. GRF and GHRF also appear as aliases in that record.NCBI Gene — Human GHRH (opens in a new tab)
The two hormone names therefore occupy different places in the pathway. A GHRH measurement and a GH measurement are not interchangeable, even if one experiment measures both.
| Measurement | What it directly describes |
|---|---|
| GHRH identity | The releasing peptide being studied |
| GH response | The downstream hormone released |
| Functional outcome | A separately measured organism-level effect |
A rise in the downstream hormone can support a releasing-factor experiment. It does not identify an unknown peptide by itself, because a biological response is not a complete structural analysis.
The original tissue source matters
Esch and colleagues’ 1983 paper characterised three GH-releasing peptides from a human pancreatic carcinoma associated with acromegaly. The reported forms contained 44, 40 and 37 residues with a shared amino-terminal sequence.Esch and colleagues — Structures of three pancreatic GH-releasing peptides (opens in a new tab)
The 44-residue form was amidated, while the 40- and 37-residue forms had free carboxyl termini. Length and terminal chemistry therefore both distinguished the isolated molecules.Esch and colleagues — Structures of three pancreatic GH-releasing peptides (opens in a new tab)
Those findings describe what was isolated from that tumour. They should not be used alone to claim that every listed form has the same abundance or role in normal hypothalamic tissue.
How the endogenous reference was connected
Ling and colleagues’ 1984 study isolated GH-releasing factor from human hypothalamic-hypophysial tissue. Sequence analysis and comparison with synthetic material established a 44-residue amidated structure matching the earlier pancreatic-tumour peptide.Ling and colleagues — Human hypothalamic somatocrinin (opens in a new tab)
The important advance was the direct molecular connection across the tissue sources. It did not depend solely on a similar GH-releasing effect or an antibody reacting with both samples.
An earlier 1984 immunoreactivity study by Lin and colleagues had provided supportive chromatographic evidence from human stalk median eminence. Its antibody strongly favoured the 44-residue amidated form over the 40-residue free-acid form.Lin and colleagues — Immunoreactive GRF in human stalk median eminence (opens in a new tab)
That assay specificity affects interpretation of the tissue result. A method designed around one terminus cannot be assumed to count every related molecular form equally.
Read the historical studies as complementary steps: recognition and chromatographic similarity supported the hypothesis; direct sequence work resolved a more specific structural question.
Use the endogenous sequence as a comparison anchor
For a later GHRH-derived preparation, record which part of the reference remains, which residues change and which terminal groups are present. Keep those fields separate from the salt name and formulation.
A shorter fragment may be deliberately chosen for an experiment, but it is still a specified fragment. A modified longer molecule is an analogue, not an unchanged endogenous reference simply because its length matches.
This article establishes the parent reference. The sermorelin and tesamorelin articles handle their own molecular definitions and clinical-study boundaries, avoiding a repeated catalogue benefits list here.
Sources and further detail
- NCBI Gene — Human GHRH (opens in a new tab)
Official RefSeq summary and aliases read for precursor processing and hypothalamic–pituitary relationship.
- Esch and colleagues — Structures of three pancreatic GH-releasing peptides (opens in a new tab)
Original 1983 abstract read. Tumour source, lengths and different carboxyl termini retained; isolation procedures not reproduced.
- Ling and colleagues — Human hypothalamic somatocrinin (opens in a new tab)
Original 1984 abstract read for direct sequence identification and match to the 44-residue pancreatic form.
- Lin and colleagues — Immunoreactive GRF in human stalk median eminence (opens in a new tab)
Original 1984 abstract read. Antibody specificity and chromatographic similarity distinguished from a full independent sequence determination.
Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.